GUARD THERAPEUTICS INTERNATIONAL AB

Insiders Guard Therapeutics International AB

Equities

GUARD

SE0021181559

Market Closed - Nasdaq Stockholm Other stock markets 11:29:48 2024-05-20 EDT			5-day change	1st Jan Change
35 ^SEK	-4.89%		-7.89%	-2.23%

05-08	Guard Therapeutics International AB Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-15	Guard Therapeutics Receives First Regulatory Approval for the Phase 2b Study POINTER	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Guard Therapeutics International AB Appoints Nomination Committee for 2024	12-07	CI
Guard Therapeutics presents the Nomination Committee for 2023	22-12-20	AQ
Guard Therapeutics International AB Announces Nomination Committee Appointments	22-12-20	CI
Guard Therapeutics International AB Appoints Torbjörn Larsson as Head of CMC (Chemistry, Manufacturing and Controls), Effective 1 May 2022	22-04-26	CI
Guard Therapeutics Appoints Michael Reusch as Chief Medical Officer, Effective January 1, 2022	21-12-15	CI
Guard Therapeutics appoints Sara Thuresson as Head of Clinical Operations	21-02-15	CI
Guard Therapeutics Appoints Ann-Kristin Myde as Head of Global Project Management, Effective 1 April 2021	20-12-28	CI
Guard Therapeutics Appoints Peter Gilmour as Head of Preclinical Science, Effective 1 August 2020	20-07-06	CI
A1M Pharma AB will Change its Name to Guard Therapeutics International AB	19-10-29	CI
A1M Pharma Appoints Tobias Larsson Agervald as Chief Medical Officer	18-08-14	CI
A1M Pharma Appoints Martin Austin as Business Development Director	15-09-25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW